Ibogaine research is being conducted to address the opioid epidemic

In an unprecedented move against the opioid epidemic, Kentucky has launched a groundbreaking $42 million program to probe the potential of ibogaine. This naturally-occurring psychedelic has shown considerable promise in reducing dependency on opioids.